From: KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells
Cell line
GI50for
ARRY-520, μM
Paclitaxel, μM
A2780
0.0015
0.2
CP70
01–28
R182
>3
>20
01–19b
R1140